Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy.
Bektaş
Ahmet
A
Cakar
Burcu
B
Ustaoğlu
Müge
M
Turgut
Mehmet
M
Bakir
Tülay
T
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects; D017809:Fatal Outcome; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000821:virology*; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D014212:Tretinoin / Q000009:adverse effects; D014775:Virus Activation / Q000187:drug effects
D000970:Antineoplastic Agents; D003561:Cytarabine; D014212:Tretinoin; D015255:Idarubicin